HEPSA

Refine your search

Your search returned 106 results.

Sort
Results
COVID-19 vaccine FAQs - hepatitis and liver disease

by Hepatitis Queensland.

Brisbane Hepatitis Queensland 2022 (rev)Online access: Click here to access online Availability: Items available for loan: 1 .
Preparing for COVID-19 when you have liver disease

by Hepatitis Queensland.

Brisbane Hepatitis Queensland 2022Online access: Click here to access online Availability: Items available for loan: 1 .
Viral hepatitis mapping project: geographic diversity in chronic hepatitis B and C prevalence, management and treatment. Alt title: National Report 2020

by MacLachlan J H | Stewart S | Cowie B C | Aust Society for HIV, Viral Hepatitis & Sexual Health Medicine (ASHM) | WHO Collaborating Centre for Viral Hepatitis | Peter Doherty Institute for Infection & Immunity.

Sydney Aust Society for HIV, Viral Hepatitis & Sexual Health Medicine (ASHM) 2020Online access: Go to report info page with links | Link to Mapping Project home page Availability: Items available for loan: 1 .
What to know about PCR tests

by Medical News Today.

Series: Medical News TodayBexhill-on-Sea Medical News Today 2022Online access: Click here to access online Availability: Items available for loan: 1 .
COVID-19 vaccine acceptability among people in Australia who inject drugs : update from the 2021 Illicit Drug Reporting System interviews

by Price O | Dietze P M | Maher L | et al.

Series: Drug and Alcohol ReviewMelbourne John Wiley & Sons 2022Online access: Link to abstract | Link to article pDF (open access) Availability: Items available for loan: 1 .
Addressing COVID-19 vaccine hesitancy among people in Australia who regularly inject drugs

by Price O.

Sydney National Drug & Alcohol Research Centre (NDARC) 2022Online access: Click here to access online Availability: Items available for loan: 1 .
The importance of prisons in achieving hepatitis C elimination: insights from the Australian experience

by Rebecca J | Winter R J | Holmes J A | et al.

Series: Viruses ; vol 14 (3)Basel Swi MDPI 2022Online access: Click here to access online Availability: Items available for loan: 1 .
COVID-19 vaccine acceptability among people who inject drugs in Melbourne

by Dietze P | Hall C | Maher L | et al.

Series: COVID-19 Impacts Bulletin ; No. 3Melbourne Burnet Institute 2021Online access: Direct link to PDF Availability: Items available for loan: 1 .
Update for people with liver disease on the Covid-19 vaccine (FAQs)

by British Liver Trust.

London British Liver Trust 2021Online access: Click here to access online Availability: Items available for loan: 1 .
Key findings from the ‘Australians’ Drug Use: Adapting to Pandemic Threats’ (ADAPT) Study: wave 3

by Sutherland R Baillie G Memedovic S et al.

Series: ADAPT Bulletin ; No 3Sydney National Drug & Alcohol Research Centre (NDARC) 2021Online access: Link to info page | Link to ADAPT Study results page | Direct link to report PDF Availability: Items available for loan: 1 .
Statement from the ASHM COVID-19 Taskforce regarding the Prioritisation of COVID-19 Vaccines for People Living with Blood-borne virus-related Chronic Liver Disease

by Taskforce on BBVs, Sexual Health & COVID-19.

Sydney Aust Society for HIV, Viral Hep & Sexual Health Medicine (ASHM) 2021Online access: Click here to access online Availability: Items available for loan: 1 .
Impacts of COVID-19 on BBVSTI testing, care and treatment: Medicare data analysis

by WHO Collaborating Centre for Viral Hepatitis | Peter Doherty Institute for Infection and Immunity.

Melbourne Peter Doherty Institute for Infection and Immunity 2021Online access: Click here to access online Availability: Items available for loan: 1 .
FAQs for clinicians about covid-19 vaccines and people living with Hepatitis B/Hepatitis C-related chronic liver disease

by Taskforce on BBVs, Sexual Health & COVID-19.

Sydney Aust Society for HIV, Viral Hep & Sexual Health Medicine (ASHM) 2021Online access: Link to source page | Direct link to PDF Availability: Items available for loan: 1 .
COVID‐19 vaccination among people who inject drugs: leaving no one behind (editorial)

by Iversen J | Peacock A | Price O | et al.

Series: Drug and Alcohol Review ; Vol 40, Issue 4Melbourne John Wiley & Sons 2021Online access: Link to source page Availability: Items available for loan: 1 .
COVID 19 case studies: hepatitis. peripheral ischemia, and pulmonary embolism

by Biscali L.

Series: Infectious Disease AdvisorNew York Infectious Disease Advisor 2021Online access: Click here to access online Availability: Items available for loan: 1 .
COVID-19 and liver disease: mechanistic and clinical perspectives

by Marjot T | Webb G J | Barritt A S | et al.

Series: Nature Reviews Gastroenterology & Hepatology ; Vol. 18London Springer Nature 2021Online access: Click here to access online Availability: Items available for loan: 1 .
Trends in, and characteristics associated with, trouble accessing sterile needles and syringes among people who inject drugs in Sydney, New South Wales

by Chandrasena U | Price O | Sutherland R.

Series: IDRS | Drug Trends BulletinSydney National Drug & Alcohol Research Centre (NDARC) 2021Online access: Link to source page | Direct link to report PDF Availability: Items available for loan: 1 .
COVID-19 vaccination in patients with gastrointestinal and liver disorders

by Gastroenterological Society of Australia (GESA).

Melbourne Gastroenterological Society of Australia (GESA) 2021Online access: Link to advice document for providers | Link to COVID-19 Vaccination patient information Availability: Items available for loan: 1 .
What is the link between hepatitis C and COVID-19?

by Goodwin M | Martin L.

Series: Medical News TodayBexhill-on-Sea Medical News Today 2021Online access: Click here to access online Availability: Items available for loan: 1 .
Pages